Intra‐Articular Administration of Autologous Micro‐Fragmented Adipose Tissue in Dogs with Spontaneous Osteoarthritis: Safety, Feasibility, and Clinical Outcomes
Abstract
Similar to the disease affecting humans, osteoarthritis (OA) is a painful musculoskeletal condition affecting 20% of the adult canine population. Several solutions have been proposed, but the results achieved to date are far from being satisfactory. New approaches, such as intra‐articular delivery of cells (including mesenchymal stromal cells), have been proposed. Among the many sources, the adipose tissue is considered very promising. We evaluated the safety, feasibility, and efficacy of a single intra‐articular injection of autologous and micro‐fragmented adipose tissue (MFAT) in 130 dogs with spontaneous OA. MFAT was obtained using a minimally invasive technique in a closed system and injected in the intra‐ and/or peri‐articular space. Clinical outcomes were determined using orthopedic examination and owners’ scores for up to 6 months. In 78% of the dogs, improvement in the orthopedic score was registered 1 month after treatment and continued gradually up to 6 months when 88% of the dogs improved, 11% did not change, and 1% worsened compared with baseline. Considering the owners’ scores at 6 months, 92% of the dogs significantly improved, 6% improved only slightly, and 2% worsened compared with baseline. No local or systemic major adverse effects were recorded. The results of this study suggest that MFAT injection in dogs with OA is safe, feasible, and beneficial. The procedure is time sparing and cost‐effective. Post injection cytological investigation, together with the clinical evidence, suggests a long‐term pain control role of this treatment. The spontaneous OA dog model has a key role in developing successful treatments for translational medicine. Stem Cells Translational Medicine 2018;7:819–828
Number of times cited according to CrossRef: 6
- Sara Nava, Valeria Sordi, Luisa Pascucci, Carlo Tremolada, Emilio Ciusani, Offer Zeira, Moris Cadei, Gianni Soldati, Augusto Pessina, Eugenio Parati, Mark Slevin and Giulio Alessandri, Long-Lasting Anti-Inflammatory Activity of Human Microfragmented Adipose Tissue, Stem Cells International, 10.1155/2019/5901479, 2019, (1-13), (2019).
- Giulio Alessandri, Valentina Coccè, Fabio Pastorino, Rita Paroni, Michele Dei Cas, Francesco Restelli, Bianca Pollo, Laura Gatti, Carlo Tremolada, Angiola Berenzi, Eugenio Parati, Anna Teresa Brini, Gianpietro Bondiolotti, Mirco Ponzoni and Augusto Pessina, Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy, Journal of Controlled Release, 10.1016/j.jconrel.2019.03.016, (2019).
- Stuart P. Atkinson, A Preview of Selected Articles, STEM CELLS Translational Medicine, 7, 11, (759-761), (2018).
- Stefan Arnhold, Mohamed I. Elashry, Michele C. Klymiuk and Sabine Wenisch, Biological macromolecules and mesenchymal stem cells: Basic research for regenerative therapies in veterinary medicine, International Journal of Biological Macromolecules, 10.1016/j.ijbiomac.2018.11.158, (2018).
- Dieter Sellmann, Shaban Y. Shaban and Frank W. Heinemann, Syntheses, Structures and Reactivity of Electron‐Rich Fe and Ru Complexes with the New Pentadentate Ligand Et2NpyS4−H2 {4‐(Diethylamino)2,6‐bis[(2‐mercaptophenyl)thiomethyl]pyridine}, European Journal of Inorganic Chemistry, 2004, 23, (4591-4601), (2004).
- Silvio Laureti, Paolo Gionchetti, Alberta Cappelli, Laura Vittori, Federico Contedini, Fernando Rizzello, Rita Golfieri, Massimo Campieri and Gilberto Poggioli, Refractory Complex Crohn’s Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection, Inflammatory Bowel Diseases, 10.1093/ibd/izz051, (2019).





